Jeff Ajer is the Chief Commercial Officer at Mendra, a biopharmaceutical executive with deep expertise in rare diseases. At his prior role as CCO of BioMarin, he scaled annual revenue from $400M to over $2B and led five successful brand launches. He holds both an MBA and a BS from UC Irvine.
He spearheaded the creation of the global commercial infrastructure at BioMarin during a period of intense growth, establishing its international footprint. He also serves on the board of directors for both Viridian Therapeutics and Nektar Therapeutics, advising on commercial strategy and governance.
Unique fact: Jeff was directly responsible for the commercial strategy that grew BioMarins revenue by over 500% during his tenure as CCO.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.